Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Physical Inactivity Is a Risk Factor for Primary Ventricular Fibrillation.
De Ferrari GM, Dusi V, Ruffinazzi M, Gionti V, Cacciavillani L, Noussan P, Zacà V, Sanna T, Crotti L, Schwartz PJ. De Ferrari GM, et al. Among authors: dusi v. J Am Coll Cardiol. 2019 Apr 30;73(16):2117-2118. doi: 10.1016/j.jacc.2019.01.063. J Am Coll Cardiol. 2019. PMID: 31023436 Free article. No abstract available.
Drug safety evaluation of dronedarone in atrial fibrillation.
De Ferrari GM, Dusi V. De Ferrari GM, et al. Among authors: dusi v. Expert Opin Drug Saf. 2012 Nov;11(6):1023-45. doi: 10.1517/14740338.2012.722994. Epub 2012 Sep 13. Expert Opin Drug Saf. 2012. PMID: 22971242 Review.
Ranolazine in the treatment of atrial fibrillation: Results of the dose-ranging RAFFAELLO (Ranolazine in Atrial Fibrillation Following An ELectricaL CardiOversion) study.
De Ferrari GM, Maier LS, Mont L, Schwartz PJ, Simonis G, Leschke M, Gronda E, Boriani G, Darius H, Guillamón Torán L, Savelieva I, Dusi V, Marchionni N, Quintana Rendón M, Schumacher K, Tonini G, Melani L, Giannelli S, Alberto Maggi C, Camm AJ; RAFFAELLO Investigators (see Online Supplementary Appendix for List of Participating Centers and Investigators). De Ferrari GM, et al. Among authors: dusi v. Heart Rhythm. 2015 May;12(5):872-8. doi: 10.1016/j.hrthm.2015.01.021. Epub 2015 Jan 17. Heart Rhythm. 2015. PMID: 25602175 Clinical Trial.
Clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic Denervation.
De Ferrari GM, Dusi V, Spazzolini C, Bos JM, Abrams DJ, Berul CI, Crotti L, Davis AM, Eldar M, Kharlap M, Khoury A, Krahn AD, Leenhardt A, Moir CR, Odero A, Olde Nordkamp L, Paul T, Rosés I Noguer F, Shkolnikova M, Till J, Wilde AA, Ackerman MJ, Schwartz PJ. De Ferrari GM, et al. Among authors: dusi v. Circulation. 2015 Jun 23;131(25):2185-93. doi: 10.1161/CIRCULATIONAHA.115.015731. Epub 2015 May 27. Circulation. 2015. PMID: 26019152 Free article.
Response to Letters Regarding Article, "Clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic Denervation".
De Ferrari GM, Dusi V, Spazzolini C, Bos JM, Abrams DJ, Berul CI, Crotti L, Eldar M, Kharlap M, Khoury A, Krahn AD, Leenhardt A, Moir CR, Odero A, Nordkamp LO, Paul T, I Noguer FR, Shkolnikova M, Till J, Wilde AA, Ackerman MJ, Schwartz PJ. De Ferrari GM, et al. Among authors: dusi v. Circulation. 2016 Jan 26;133(4):e366-7. doi: 10.1161/CIRCULATIONAHA.115.019465. Circulation. 2016. PMID: 26811283 No abstract available.
60 results